Extracorporeal Membrane Oxygenation Machine Market Outlook (2022 to 2032)

The global extracorporeal membrane oxygenation machine market size stood at US$ 531 Million in 2022 and is expected to grow at a steady CAGR of 5% during the forecast period from 2022 to 2032, reaching a valuation of US$ 908 Billion by the end of 2032.

The rising adoption of extracorporeal membrane oxygenation machines is attributed to the increasing prevalence of chronic diseases and rapid growth in organ transplantation procedures worldwide.

Data Points Market Insights
Extracorporeal Membrane Oxygenation Machine Market Value 2022 US$ 531 Million
Extracorporeal Membrane Oxygenation Machine Market Value 2026 US$ 673 Million
Extracorporeal Membrane Oxygenation Machine Market Projected Value 2032 US$ 908 Million
Extracorporeal Membrane Oxygenation Machine Market Forecast CAGR (2022 to 2032) 5%
Key Players Medtronic plc (USA), Fresenius Medical Care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Origin Biomedical (USA), Terumo Cardiovascular Systems Corporation, Livanova plc (United Kingdom), Nipro Corporation (Japan), Euro sets S.R.L. (Italy), Cytosorbents Corporation (Australia), and Abiomed.

Rising complications during surgical procedures like heart transplants have prompted medical professionals to adopt innovative devices like extracorporeal membrane oxygenation machines in healthcare settings.

Extracorporeal membrane oxygenation machines are advanced medical devices used to provide prolonged cardiac and respiratory support to persons whose hearts and lungs are unable to function properly. They have become ideal tools used in the care of adults and children with severe cardiac and pulmonary dysfunction.

These machines are mostly used when all the other medical options prove ineffective for patients whose lungs can’t provide enough oxygen to their body or can’t get rid of carbon dioxide. ECMO machines can also be used for patients undergoing heart or lung transplants.

The increasing prevalence of chronic diseases coupled with a rapid surge in heart and lung transplants is emerging as a key factor in boosting the sales of extracorporeal membrane oxygenation machines and the trend is likely to escalate during the forecast period.

Leading extracorporeal oxygenation machine manufacturers are continuously innovating to develop advanced products that can help end users effectively treat patients with heart or lung failures. For instance, in 2020, INTEGRIS Health and EMSA unveiled a one-of-a-kind specialty care ECMO ambulance.

Advancements in lung pulmonary airway disease treatment, the presence of favorable reimbursement policies, and the expansion of the healthcare industry across developing regions of Asia and Africa will further expand the extracorporeal membrane oxygenation machine market size during the forthcoming years.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2015 to 2021 Market Demand Outlook For Extracorporeal Membrane Oxygenation Machine Market Compared To 2022 to 2032 Forecast

The global demand for extracorporeal membrane oxygenation machines is anticipated to grow at a moderate CAGR of 5% during the forecast period between 2022 and 2032. Growth in the market is driven by the rising prevalence of cardiovascular and respiratory diseases, the growing adoption of ECMO in lung and heart transplantation procedures, an increase in the number of ECMO centers, and advancements in extracorporeal membrane oxygenation machines.

Extracorporeal membrane oxygenation has become one of the most widely used techniques for providing effective circulation and respiratory support in critically ill patients. It has emerged as an ideal alternative to cardiopulmonary bypass (CPB) used during organ transplantation procedures.

The increasing prevalence of chronic diseases such as COPD and along with the rise in the number of heart and lung transplantation procedures being performed is providing a major impetus to the extracorporeal membrane oxygenation machine market growth.

As per the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide in 2019, causing around 3.23 million deaths. This rise in the mortality rate of respiratory and cardiovascular diseases will continue to expand the extracorporeal membrane oxygenation machine market size during the forthcoming years.

Similarly, the growing geriatric population and favorable government laws, investments, and initiatives are creating growth avenues within the global extracorporeal membrane oxygenation machine market.

ECMO machines offer various benefits such as higher speed and short processing times which is fueling their adoption across various end-use verticals such as intensive care units, operating rooms, cardiac catheterization labs, and emergency departments.

The outbreak of COVID-19 created new opportunities for ECMO equipment manufacturers during the last few years. They become essential tools for improving the survival chances of severe COVID-19 patients.

What are the Challenges Faced by the Extracorporeal Membrane Oxygenation Machine Market?

There is no doubt that sales of extracorporeal membrane oxygenation machines are gathering huge across end-use verticals. However, there are various factors that are slowing down the growth of the extracorporeal membrane oxygenation machine market.

Some of these factors are the increasing extracorporeal membrane oxygenation machine prices due to frequent advancements, scarcity of qualified professionals, and low availability of these devices in some regions.

Country-Wise Insights

What Makes the USA Most Dominant Market for Extracorporeal Membrane Oxygenation Machines?

Rise in Organ Transplantation Procedures Augmenting Demand for ECMO Machines in the USA

As per FMI, the USA will continue to remain the most lucrative market for extracorporeal membrane oxygenation machines during the forecast period, owing to the rapidly developing healthcare sector, rising adoption of advanced technologies, the surge in the number of lung cancer surgeries performed, the heavy presence of leading medical device manufacturers, favorable government support, and increasing prevalence of chronic diseases.

The United States has one of the most developed and sophisticated healthcare industries in the world. Both government and non-government organizations are putting efforts to make advanced medical technologies available to healthcare professionals across the country. This will continue to generate lucrative opportunities for ECMO machine manufacturers during the forecast period.

Similarly, a sharp rise in the number of organ transplants is fueling the adoption of ECMO machines in the country. According to the Health Resource and Service Administration (HRSA), the number of heart transplants performed in adults alone rose to 3715 in 2020.

Why is Demand for Extracorporeal Membrane Oxygenation Machines Rising Across Japan?

Rise in Organ Transplantation Procedures Creating Demand for ECMO Machines in Japan

In recent years, demand for ECMO machines has risen at a significant pace across Japan and this trend is likely to continue during the forecast period, owing to the rising geriatric population, increasing healthcare spending, surge in chronic disease cases, booming organ transplant market, favorable government initiatives, and availability of advanced medical technologies.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-Wise Insights

Which Product is the Top Selling Product in the Global Extracorporeal Membrane Oxygenation Machine Market?

Demand for ECMO Machines to Remain High Throughout the Forecast Period

By product, the global extracorporeal membrane oxygenation machine market has been segmented into ECMO machines and software. Among these, the ECMO machines segment dominated the extracorporeal membrane oxygenation machine market in 2021 and is forecast to grow at a relatively higher CAGR over the assessment period.

Factors such as the growing popularity of portable ECMO devices, the booming healthcare industry, and the expansion of the portable medical devices market are favoring the growth of this segment.

FMI’s latest extracorporeal membrane oxygenation machine market forecast indicates that demand for portable ECMO machines will rise at a substantial pace amid the rising adoption of homecare medical devices across developed and developing regions.

Which Service Type Leads the Global Extracorporeal Membrane Oxygenation Machine Market?

Application Segment to Account for Majority of Revenue Share

Based on service type, the extracorporeal membrane oxygenation machine market is segmented into application, middleware, and infrastructure. Among these, the application segment leads the market growth, accounting for the bulk of the revenue share generated in the market. The rising frequency of target diseases, increasing sales of ECMO machines, and technological improvements in ECMO machines contribute to the growth of this segment.

Which Component Contributes the Most to the Growth of Extracorporeal Membrane Oxygenation Machine Market?

Sales of Controllers to Continue Rising in the Extracorporeal Membrane Oxygenation Machine Market

As per FMI, the controller's segment is expected to dominate the extracorporeal membrane oxygenation machine market during the projected period. The rising adoption of controllers by end-users is a major factor triggering the growth of this segment.

By Modality Which Segment Holds the Largest Share in Extracorporeal Membrane Oxygenation Machine Market?

Arterio-Venous Remains the Most Preferred Modality Type

The latestextracorporeal membrane oxygenation machine market trends reveal that the arterio-venous segment will continue to lead the global extracorporeal membrane oxygenation machine market during the forecast period, owing to the various benefits such as highly effective nature and better medical evaluation associated with this technology.

Competitive Landscape

Leading extracorporeal membrane oxygenation machine manufacturers are constantly focusing on new product launches and approvals for expanding their product portfolios. Besides this, they have adopted growth strategies such as partnerships, acquisitions, mergers, joint ventures, and collaborations to gain a competitive edge in the global extracorporeal membrane oxygenation machine market.

For instance:

  • In 2020, the USA Food and Drug Administration (FDA) approved the Novalung extracorporeal membrane oxygenation (ECMO) machine to treat acute respiratory or cardiopulmonary failure.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Extracorporeal Membrane Oxygenation Machine Market Report Scope

FMI’s latest market survey uncovers key investment pockets within the extracorporeal membrane oxygenation machine market. It analyses how key extracorporeal membrane oxygenation machine manufacturers are innovating to meet end-user demands.

The study provides inclusive details about the extracorporeal membrane oxygenation machine ecosystem and highlights key market governing factors such as growth drivers, restraints, and emerging opportunities. Besides this, it discusses in detail the latest extracorporeal membrane oxygenation machine market trends.

FMI also offers exhaustive research into factors pushing demand for extracorporeal membrane oxygenation machines across developed and developing regions. It attempts to explore the growth potential of regions with a high patient pool and explain how advancements in medical device technologies are affecting extracorporeal membrane oxygenation machine sales.

Want to get a comprehensive assessment of the extracorporeal membrane oxygenation machine market and much more Keep in touch with Future Market Insights, one of the leading research companies in the world.

The Extracorporeal Membrane Oxygenation Machine Market analysis includes:

  • A 10-year realistic extracorporeal membrane oxygenation machine sales forecast across multiple verticals
  • Detailed analysis of regional pockets along with the degree of market penetration
  • Impact of evolving respiratory devices on extracorporeal membrane oxygenation machine market forecast.
  • Exclusive recommendations on how to penetrate attractive ECMO machine markets of Asia, Africa, and others.
  • Insights into emerging end-user demands and current extracorporeal membrane oxygenation machine market trends.
  • Top extracorporeal membrane oxygenation machine manufacturers and their growth strategies
  • Market dynamics including drivers, restraints, and emerging opportunities
  • Compelling insights into various products and service types in the extracorporeal membrane oxygenation machines market.
  • Pricing analysis
  • The winning imperatives in the extracorporeal membrane oxygenation machine market.
Attribute Details
Forecast Period 2022 to 2032
Historic Data Available for 2015 to 2021
Market Analysis US$ Million for Value
Report Coverage Market forecast, company share analysis, competition intelligence, Drivers, Restraints, Opportunities and Threats analysis, market dynamics and challenges, and strategic growth initiatives
Key Segments Covered By product, By Service Type, By Component, By Modality, By Patient Type, By Region
Key regions covered North America
  • USA
  • Canada
  • Rest of North America
Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
Western Europe
  • Germany
  • United Kingdom
  • France
  • Rest of Western Europe
Eastern Europe
  • Russia
  • Spain
  • Rest of Eastern Europe
South Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • Thailand
  • Indonesia
  • South Korea
  • Rest of South Asia & Pacific
Middle East & Africa
  • GCC Countries
  • Turkey
  • Israel
  • Rest of the Middle East and Africa(MEA)
Rest of the World
  • Oceania
  • Africa
  • South America
Patient Type
  • Neonates
  • Pediatrics
  • Adults
Key companies profiled Medtronic plc (USA), Fresenius Medical Care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Origin Biomedical (USA), Terumo Cardiovascular Systems Corporation, Livanova plc (United Kingdom), Nipro Corporation (Japan), Euro sets S.R.L. (Italy), Cytosorbents Corporation (Australia), and Abiomed.
Customization & pricing Available upon request

Key Segments

By Product:

  • ECMO Machines
    • Portable Devices
    • Static Devices
  • Software

By Service Type:

  • Application
  • Middleware
  • Infrastructure

By Component:

  • Pumps
  • Oxygenators
  • Controllers
  • Cannula
  • Accessories

By Modality:

  • Veno-Venous
  • Veno-Arterials
  • Arterio-Venous

By Patient Type:

  • Neonates
  • Pediatrics
  • Adults

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

How much is the global extracorporeal membrane oxygenation machine market worth?

The global extracorporeal membrane oxygenation market was estimated to be worth US$ 531 Million in 2022.

What is the growth projection for extracorporeal membrane oxygenation machine market?

As per FMI, the global extracorporeal membrane oxygenation machine market is expected to grow at 5% CAGR during the forecast period, totaling US$ 908 Million by 2032.

Which are some of the prominent extracorporeal membrane oxygenation machine manufacturers?

Medtronic plc (USA), Fresenius Medical Care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Terumo Cardiovascular Systems Corporation, Livanova plc (UK), Nipro Corporation (Japan) are some of the leading companies operating in the extracorporeal oxygenation machine market.

Table of Content

1. Executive Summary | Extracorporeal Membrane Oxygenation Machine Market

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. FMI Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Million)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. Market, by Key Countries

    4.2. Market Opportunity Assessment (US$ Million)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in Optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032

    6.1. Historical Market Analysis, 2015 to 2021

    6.2. Current and Future Market Projections, 2022 to 2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032

    7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021

    7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Component

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Million) and Analysis By Component, 2015 to 2021

    8.3. Current and Future Market Value (US$ Million) and Analysis and Forecast By Component, 2022 to 2032

        8.3.1. Pumps

        8.3.2. Oxygenators

        8.3.3. Controllers

        8.3.4. Cannul

        8.3.5. Accessories

    8.4. Market Attractiveness Analysis By Component

9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Million) and Analysis By Product, 2015 to 2021

    9.3. Current and Future Market Value (US$ Million) and Analysis and Forecast By Product, 2022 to 2032

        9.3.1. ECMO Machines

            9.3.1.1. Portable Devices

            9.3.1.2. Static Devices

        9.3.2. Software

    9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Provider

    10.1. Introduction / Key Findings

    10.2. Historical Market Value (US$ Million) and AnalysisBy Provider, 2015 to 2021

    10.3. Current and Future Market Value (US$ Million) and Analysis and ForecastBy Provider, 2022 to 2032

        10.3.1. Application

        10.3.2. Middleware

        10.3.3. Infrastructure

    10.4. Market Attractiveness AnalysisBy Provider

11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Modality

    11.1. Introduction / Key Findings

    11.2. Historical Market Value (US$ Million) and Analysis By Modality, 2015 to 2021

    11.3. Current and Future Market Value (US$ Million) and Analysis and Forecast By Modality, 2022 to 2032

        11.3.1. Veno-Venous

        11.3.2. Veno-Arterials

        11.3.3. Arterio-Venous

    11.4. Market Attractiveness Analysis By Modality

12. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Patient Type

    12.1. Introduction / Key Findings

    12.2. Historical Market Value (US$ Million) and Analysis By Patient Type, 2015 to 2021

    12.3. Current and Future Market Value (US$ Million) and Analysis and Forecast By Patient Type, 2022 to 2032

        12.3.1. Neonates

        12.3.2. Pediatrics

        12.3.3. Adults

    12.4. Market Attractiveness Analysis By Patient Type

13. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region

    13.1. Introduction

    13.2. Historical Market Value (US$ Million) and Analysis By Region, 2015 to 2021

    13.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. Asia Pacific

        13.3.5. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Million) and Trend Analysis By Market Taxonomy, 2015 to 2021

    14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        14.4.1. By Country

            14.4.1.1. USA

            14.4.1.2. Canada

            14.4.1.3. Rest of North America

        14.4.2. By Provider

        14.4.3. By Component

        14.4.4. By Product

        14.4.5. By Modality

        14.4.6. By Patient Type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Provider

        14.5.3. By Component

        14.5.4. By Product

        14.5.5. By Modality

        14.5.6. By Patient Type

15. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Million) and Trend Analysis By Market Taxonomy, 2015 to 2021

    15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        15.4.1. By Country

            15.4.1.1. Brazil

            15.4.1.2. Mexico

            15.4.1.3. Rest of Latin America

        15.4.2. By Provider

        15.4.3. By Component

        15.4.4. By Product

        15.4.5. By Modality

        15.4.6. By Patient Type

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Provider

        15.5.3. By Component

        15.5.4. By Product

        15.5.5. By Modality

        15.5.6. By Patient Type

16. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$ Million) and Trend Analysis By Market Taxonomy, 2015 to 2021

    16.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        16.4.1. By Country

            16.4.1.1. Germany

            16.4.1.2. France

            16.4.1.3. United Kingdom

            16.4.1.4. Italy

            16.4.1.5. Russia

            16.4.1.6. Rest of Europe

        16.4.2. By Provider

        16.4.3. By Component

        16.4.4. By Product

        16.4.5. By Modality

        16.4.6. By Patient Type

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Provider

        16.5.3. By Component

        16.5.4. By Product

        16.5.5. By Modality

        16.5.6. By Patient Type

17. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$ Million) and Trend Analysis By Market Taxonomy, 2015 to 2021

    17.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        17.4.1. By Country

            17.4.1.1. China

            17.4.1.2. Japan

            17.4.1.3. South Korea

            17.4.1.4. Rest of Asia Pacific

        17.4.2. By Provider

        17.4.3. By Component

        17.4.4. By Product

        17.4.5. By Modality

        17.4.6. By Patient Type

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Provider

        17.5.3. By Component

        17.5.4. By Product

        17.5.5. By Modality

        17.5.6. By Patient Type

18. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Value (US$ Million) and Trend Analysis By Market Taxonomy, 2015 to 2021

    18.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        18.4.1. By Country

            18.4.1.1. GCC Countries

            18.4.1.2. South Africa

            18.4.1.3. Turkey

            18.4.1.4. Rest of Middle East and Africa

        18.4.2. By Provider

        18.4.3. By Component

        18.4.4. By Product

        18.4.5. By Modality

        18.4.6. By Patient Type

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Provider

        18.5.3. By Component

        18.5.4. By Product

        18.5.5. By Modality

        18.5.6. By Patient Type

19. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. USA Market Analysis

        19.2.1. Value Proportion Analysis by Market Taxonomy

        19.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.2.2.1. By Provider

            19.2.2.2. By Component

            19.2.2.3. By Product

            19.2.2.4. By Modality

            19.2.2.5. By Patient Type

    19.3. Canada Market Analysis

        19.3.1. Value Proportion Analysis by Market Taxonomy

        19.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.3.2.1. By Provider

            19.3.2.2. By Component

            19.3.2.3. By Product

            19.3.2.4. By Modality

            19.3.2.5. By Patient Type

    19.4. Mexico Market Analysis

        19.4.1. Value Proportion Analysis by Market Taxonomy

        19.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.4.2.1. By Provider

            19.4.2.2. By Component

            19.4.2.3. By Product

            19.4.2.4. By Modality

            19.4.2.5. By Patient Type

    19.5. Brazil Market Analysis

        19.5.1. Value Proportion Analysis by Market Taxonomy

        19.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.5.2.1. By Provider

            19.5.2.2. By Component

            19.5.2.3. By Product

            19.5.2.4. By Modality

            19.5.2.5. By Patient Type

    19.6. Germany Market Analysis

        19.6.1. Value Proportion Analysis by Market Taxonomy

        19.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.6.2.1. By Provider

            19.6.2.2. By Component

            19.6.2.3. By Product

            19.6.2.4. By Modality

            19.6.2.5. By Patient Type

    19.7. France Market Analysis

        19.7.1. Value Proportion Analysis by Market Taxonomy

        19.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.7.2.1. By Provider

            19.7.2.2. By Component

            19.7.2.3. By Product

            19.7.2.4. By Modality

            19.7.2.5. By Patient Type

    19.8. Italy Market Analysis

        19.8.1. Value Proportion Analysis by Market Taxonomy

        19.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.8.2.1. By Provider

            19.8.2.2. By Component

            19.8.2.3. By Product

            19.8.2.4. By Modality

            19.8.2.5. By Patient Type

    19.9. Russia Market Analysis

        19.9.1. Value Proportion Analysis by Market Taxonomy

        19.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.9.2.1. By Provider

            19.9.2.2. By Component

            19.9.2.3. By Product

            19.9.2.4. By Modality

            19.9.2.5. By Patient Type

    19.10. United Kingdom Market Analysis

        19.10.1. Value Proportion Analysis by Market Taxonomy

        19.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.10.2.1. By Provider

            19.10.2.2. By Component

            19.10.2.3. By Product

            19.10.2.4. By Modality

            19.10.2.5. By Patient Type

    19.11. China Market Analysis

        19.11.1. Value Proportion Analysis by Market Taxonomy

        19.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.11.2.1. By Provider

            19.11.2.2. By Component

            19.11.2.3. By Product

            19.11.2.4. By Modality

            19.11.2.5. By Patient Type

    19.12. Japan Market Analysis

        19.12.1. Value Proportion Analysis by Market Taxonomy

        19.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.12.2.1. By Provider

            19.12.2.2. By Component

            19.12.2.3. By Product

            19.12.2.4. By Modality

            19.12.2.5. By Patient Type

    19.13. South Korea Market Analysis

        19.13.1. Value Proportion Analysis by Market Taxonomy

        19.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.13.2.1. By Provider

            19.13.2.2. By Component

            19.13.2.3. By Product

            19.13.2.4. By Modality

            19.13.2.5. By Patient Type

    19.14. GCC Countries Market Analysis

        19.14.1. Value Proportion Analysis by Market Taxonomy

        19.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.14.2.1. By Provider

            19.14.2.2. By Component

            19.14.2.3. By Product

            19.14.2.4. By Modality

            19.14.2.5. By Patient Type

    19.15. South Africa Market Analysis

        19.15.1. Value Proportion Analysis by Market Taxonomy

        19.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.15.2.1. By Provider

            19.15.2.2. By Component

            19.15.2.3. By Product

            19.15.2.4. By Modality

            19.15.2.5. By Patient Type

    19.16. Turkey Market Analysis

        19.16.1. Value Proportion Analysis by Market Taxonomy

        19.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032

            19.16.2.1. By Provider

            19.16.2.2. By Component

            19.16.2.3. By Product

            19.16.2.4. By Modality

            19.16.2.5. By Patient Type

        19.16.3. Competition Landscape and Player Concentration in the Country

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Concentration

    20.3. Market Share Analysis of Top Players

    20.4. Market Presence Analysis

        20.4.1. By Regional Footprint of Players

        20.4.2. Product Footprint by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. FRESENIUS MEDICAL CARE

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Sales Footprint

            21.3.1.4. Strategy Overview

        21.3.2. GETINGE GROUP

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Sales Footprint

            21.3.2.4. Strategy Overview

        21.3.3. MEDTRONIC PLC

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Sales Footprint

            21.3.3.4. Strategy Overview

        21.3.4. MICROPORT

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Sales Footprint

            21.3.4.4. Strategy Overview

        21.3.5. TERUMO CARDIOVASCULAR SYSTEMS CORPORATION

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Sales Footprint

            21.3.5.4. Strategy Overview

        21.3.6. NIPRO CORPORATION

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Sales Footprint

            21.3.6.4. Strategy Overview

        21.3.7. LIVANOVA PLC

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Sales Footprint

            21.3.7.4. Strategy Overview

        21.3.8. EUROSETS S.R.L

            21.3.8.1. Overview

            21.3.8.2. Product Portfolio

            21.3.8.3. Sales Footprint

            21.3.8.4. Strategy Overview

        21.3.9. ORIGEN BIOMEDICAL, INC

            21.3.9.1. Overview

            21.3.9.2. Product Portfolio

            21.3.9.3. Sales Footprint

            21.3.9.4. Strategy Overview

        21.3.10. CYTOSORBENTS CORPORATION

            21.3.10.1. Overview

            21.3.10.2. Product Portfolio

            21.3.10.3. Sales Footprint

            21.3.10.4. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Recommendations

Healthcare

Pain Management Devices Market

February 2022

REP-GB-14306

October 2022

315 pages

Healthcare

Extracorporeal Membrane Oxygenation Machine Market

February 2022

REP-GB-14300

May 2022

311 pages

Healthcare

Wearable Healthcare Devices Market

February 2022

REP-GB-14294

May 2022

319 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Extracorporeal Membrane Oxygenation Machine Market